Iceland· IS-EU/1/18/1345/001-002
Ondexxya
A andexanet alfa product containing andexanetum alfa inn, registered in Iceland by AstraZeneca AB*. The same ATC class is registered in 12 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Andexanet alfa is registered in 12 of 19 countries.
Countries holding a registration under ATC V03AB38 (andexanet alfa), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 7 of them publish a price we can compare per daily dose
Andexanet alfa · ATC V03AB38
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Andexanetum alfa INN
- Manufacturer
- AstraZeneca AB*
- Country
- Iceland (IS)
- ATC code
- V03AB38
- ATC class
- Andexanet alfa
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Andexanet alfa in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaONDEXXYAAstraZeneca AB, Södertälje
- SwitzerlandOndexxya 200 mg, Pulver zur Herstellung einer InfusionslösungAstraZeneca AG
- FinlandOndexxyaAstraZeneca AB
- United KingdomOndexxya 200mg powder for solution for infusion vialsAstraZeneca UK Ltd
- PolandOndexxyaAstraZeneca AB
- BelgiumOndexxya 200 mgAstraZeneca
- SwedenOndexxya 200 mg Pulver till infusionsvätska, lösningAstraZeneca AB
- SpainONDEXXYA 200 MG POLVO PARA SOLUCION PARA PERFUSIONAstrazeneca Ab
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Liechtenstein · Ondexxya
- Norway · Ondexxya
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e747fd7b-cdfc-4627-bedf-0bb888bfbd7e GET /v1/drugs/e747fd7b-cdfc-4627-bedf-0bb888bfbd7e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Innrennslisstofn, lausn",
"source": "lyfjastofnun",
"atc_raw": "V03AB38",
"marketed": false,
"strength": "200 mg",
"ma_number": "EU/1/18/1345/001-002",
"substance": "Andexanetum alfa INN",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt\r\n(H) Sjúkrahúsmerkt",
"ma_issued_serial": "43581"
}See everything about andexanet alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.